38112003: un (valeur de l'attribut)

SNOMED CT Concept\valeur de l'attribut\nombre\un

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
un	est un(e) (attribut)	modificateur adjectival général	false	Inferred relationship	Some
un	est un(e) (attribut)	nombre	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Cabazitaxel 40 mg/mL solution for injection	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Cabazitaxel 40 mg/mL solution for injection	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely interferon beta-1b 300 microgram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely interferon beta-1b 300 microgram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Ecallantide 10 mg/mL solution for injection	Count of base of active ingredient	False	un	Inferred relationship	Some
Ecallantide 10 mg/mL solution for injection	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely pemetrexed (as pemetrexed disodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely pemetrexed (as pemetrexed disodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely sodium para-aminohippurate 200 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely sodium para-aminohippurate 200 milligram/1 milliliter conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Nitroglycerin 800 microgram/hour prolonged-release transdermal patch	Count of base of active ingredient	False	un	Inferred relationship	Some
Nitroglycerin 800 microgram/hour prolonged-release transdermal patch	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Testosterone 100 mg prolonged-release subcutaneous implant	Count of base of active ingredient	False	un	Inferred relationship	Some
Testosterone 100 mg prolonged-release subcutaneous implant	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Buprenorphine 20 microgram/hour prolonged-release transdermal patch	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Buprenorphine 20 microgram/hour prolonged-release transdermal patch	Count of base of active ingredient	False	un	Inferred relationship	Some
Buprenorphine 10 microgram/hour prolonged-release transdermal patch	Count of base of active ingredient	False	un	Inferred relationship	Some
Buprenorphine 10 microgram/hour prolonged-release transdermal patch	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Hydrogen peroxide 350 mg/mL oropharyngeal solution	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Hydrogen peroxide 350 mg/mL oropharyngeal solution	Count of base of active ingredient	False	un	Inferred relationship	Some
Testosterone 200 mg prolonged-release subcutaneous implant	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Testosterone 200 mg prolonged-release subcutaneous implant	Count of base of active ingredient	False	un	Inferred relationship	Some
Dexamethasone 700 microgram prolonged-release ocular implant	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Dexamethasone 700 microgram prolonged-release ocular implant	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely ciclosporin 50 milligram/1 milliliter conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely ciclosporin 50 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Nitroglycerin 200 microgram/hour prolonged-release transdermal patch	Count of base of active ingredient	False	un	Inferred relationship	Some
Nitroglycerin 200 microgram/hour prolonged-release transdermal patch	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely goserelin (as goserelin acetate) 3.6 milligram/1 each prolonged-release subcutaneous implant (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely goserelin (as goserelin acetate) 3.6 milligram/1 each prolonged-release subcutaneous implant (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely glyceryl trinitrate 300 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely glyceryl trinitrate 300 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
méthylprednisolone 1 g, fiole de poudre pour injection (médicament clinique)	Has presentation strength numerator value (attribute)	False	un	Inferred relationship	Some	1
méthylprednisolone 1 g, fiole de poudre pour injection (médicament clinique)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
méthylprednisolone 1 g, fiole de poudre pour injection (médicament clinique)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely estradiol 25 milligram/1 each prolonged-release subcutaneous implant (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely estradiol 25 milligram/1 each prolonged-release subcutaneous implant (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely estradiol 50 milligram/1 each prolonged-release subcutaneous implant (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely estradiol 50 milligram/1 each prolonged-release subcutaneous implant (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Diclofenac potassium 50 mg powder for oral solution sachet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Diclofenac potassium 50 mg powder for oral solution sachet	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely daunorubicin (as daunorubicin hydrochloride) 5 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely daunorubicin (as daunorubicin hydrochloride) 5 milligram/1 milliliter conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely interferon alfa-2b 10 million unit/1 milliliter conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely interferon alfa-2b 10 million unit/1 milliliter conventional release solution for injection (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Amylase 25000 unit and endopeptidase 25000 unit and triacylglycerol lipase 4000 unit oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Amylase 25000 unit and endopeptidase 25000 unit and triacylglycerol lipase 4000 unit oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Amylase 25000 unit and endopeptidase 25000 unit and triacylglycerol lipase 4000 unit oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	3
Product containing precisely aldesleukin 22 million unit/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely aldesleukin 22 million unit/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Amylase 65000 unit and endopeptidase 65000 unit and triacylglycerol lipase 20000 unit oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Amylase 65000 unit and endopeptidase 65000 unit and triacylglycerol lipase 20000 unit oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Amylase 65000 unit and endopeptidase 65000 unit and triacylglycerol lipase 20000 unit oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	3
Amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 10000 unit gastro-resistant oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 10000 unit gastro-resistant oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	3
Amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 10000 unit gastro-resistant oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Varicella-zoster virus antibody 104 unit/mL solution for injection	Count of base of active ingredient	False	un	Inferred relationship	Some
Varicella-zoster virus antibody 104 unit/mL solution for injection	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely insulin lispro 25 unit/1 milliliter and insulin lispro protamine 75 unit/1 milliliter conventional release solution for injection (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely insulin lispro 25 unit/1 milliliter and insulin lispro protamine 75 unit/1 milliliter conventional release solution for injection (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	2
Product containing precisely amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 8000 unit/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 8000 unit/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	3
Product containing precisely amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 8000 unit/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Amylase 66400 unit and endopeptidase 75000 unit and triacylglycerol lipase 20000 unit gastro-resistant oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	3
Amylase 66400 unit and endopeptidase 75000 unit and triacylglycerol lipase 20000 unit gastro-resistant oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Amylase 66400 unit and endopeptidase 75000 unit and triacylglycerol lipase 20000 unit gastro-resistant oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Heparin (as porcine heparin sodium) 100 unit/mL solution for injection	Count of base of active ingredient	False	un	Inferred relationship	Some
Heparin (as porcine heparin sodium) 100 unit/mL solution for injection	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Amylase 33200 unit and endopeptidase 37500 unit and triacylglycerol lipase 10000 unit gastro-resistant oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Amylase 33200 unit and endopeptidase 37500 unit and triacylglycerol lipase 10000 unit gastro-resistant oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Amylase 33200 unit and endopeptidase 37500 unit and triacylglycerol lipase 10000 unit gastro-resistant oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	3
Product containing precisely insulin lispro 50 unit/1 milliliter and insulin lispro protamine 50 unit/1 milliliter conventional release solution for injection (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Amylase 3000 unit and endopeptidase 3000 unit and triacylglycerol lipase 2400 unit oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Amylase 3000 unit and endopeptidase 3000 unit and triacylglycerol lipase 2400 unit oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Amylase 3000 unit and endopeptidase 3000 unit and triacylglycerol lipase 2400 unit oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	3
Amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	3
Amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Product containing precisely amylase 12000 unit and endopeptidase 12000 unit and triacylglycerol lipase 4000 unit/1 each gastro-resistant oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Product containing precisely amylase 12000 unit and endopeptidase 12000 unit and triacylglycerol lipase 4000 unit/1 each gastro-resistant oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely amylase 12000 unit and endopeptidase 12000 unit and triacylglycerol lipase 4000 unit/1 each gastro-resistant oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	3
Amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 8000 unit oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	3
Amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 8000 unit oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 8000 unit oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Interferon beta-1a 24 million unit/mL solution for injection	Count of base of active ingredient	False	un	Inferred relationship	Some
Interferon beta-1a 24 million unit/mL solution for injection	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Amylase 48000 unit and endopeptidase 48000 unit and triacylglycerol lipase 16000 unit gastro-resistant oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	3
Amylase 48000 unit and endopeptidase 48000 unit and triacylglycerol lipase 16000 unit gastro-resistant oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Amylase 48000 unit and endopeptidase 48000 unit and triacylglycerol lipase 16000 unit gastro-resistant oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Heparin (as porcine heparin sodium) 10 unit/mL solution for injection	Count of base of active ingredient	False	un	Inferred relationship	Some
Heparin (as porcine heparin sodium) 10 unit/mL solution for injection	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Amylase 56000 unit and endopeptidase 44000 unit and triacylglycerol lipase 20000 unit oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Amylase 56000 unit and endopeptidase 44000 unit and triacylglycerol lipase 20000 unit oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	3
Amylase 56000 unit and endopeptidase 44000 unit and triacylglycerol lipase 20000 unit oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely amylase 16600 unit and endopeptidase 18800 unit and triacylglycerol lipase 5000 unit/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Product containing precisely amylase 16600 unit and endopeptidase 18800 unit and triacylglycerol lipase 5000 unit/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	3
Product containing precisely amylase 16600 unit and endopeptidase 18800 unit and triacylglycerol lipase 5000 unit/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely amylase 58500 unit and endopeptidase 58500 unit and triacylglycerol lipase 18000 unit/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Product containing precisely amylase 58500 unit and endopeptidase 58500 unit and triacylglycerol lipase 18000 unit/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	3

Start Previous Page 83 of 217 Next End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
33081000077110	un	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Common French translation module (core metadata concept)
3442104013	1 (qualifier value)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442105014	1	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
615211000077111	un (valeur de l'attribut)	fr	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Common French translation module (core metadata concept)
64719019	One	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
771016011	One (qualifier value)	en	Fully specified name	Inactive	Only initial character case insensitive (core metadata concept)	SNOMED CT core